The US National Institute of Health's National Center for Advancing Translational Science has announced that five more pharmaceutical companies have joined its program to find new uses for early-stage drugs that did not make it through the full pipeline, reports ScienceInsider's Jocelyn Kaiser.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.